Delivery Order SPE2DR25D3016-SPE2DR26FG2HP
- Not listed
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $7,957.71 and an ultimate completion date of October 7, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,525.70 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. IMFINZI is a specialized oncology pharmaceutical product, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,957.68 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 ml vials. This competitive award, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16.77K delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 29, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1B...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,181.60 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This contract is a firm fixed price delivery order with performance through December 31, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $41,930.85 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with a completion date of January 2, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. IMFINZI is an oncology pharmaceutical used in the treatment of certain cancers, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a $27,986.44 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 9, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,903.44 to AmerisourceBergen Drug Corp for the supply of IMFINZI (120 mg/2.4 ml vial) on October 24, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $33,544.68 to AmerisourceBergen Drug Corp for the supply of IMFINZI (500 mg/10 mL vial) on December 2, 2025, with completion scheduled for December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2HPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials on December 16, 2025. This firm fixed price delivery order, valued at $8,386.17, represents a non-set-aside competitive award with an ultimate completion date of January 8, 2026. The pharmaceuticals will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceuticals and medical commodities to support military healthcare programs worldwide, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for IMFINZI, a specialty oncology medication, exemplifies the type of critical specialty pharmaceuticals the company provides through its established federal contract relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 12/15/25 |